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Abstract vpl65 (or gpl60) is an aminopeptidase that has been 
identified as one of the major proteins of the GLUT4-containing 
vesicles. In the present study we have determined the degree of 
co-localization between vpl65 and GLUT4 in rat adipose cells 
and used perturbation by wortmannin to assess the exocytic and 
endocytic steps along the translocation and recycling pathways of 
GLUT4 in the absence and presence of insulin. Western blots of 
subcellular membrane fractions demonstrate very similar dis-
tributions of vpl65 and GLUT4. Confocal microscopy of whole 
cells provides direct evidence that these proteins share the same 
vesicle populations moving both towards and from the plasma 
membrane. These data are consistent with the presence of a 
distinct insulin-sensitive compartment that sequesters both 
GLTJT4 and vpl65 and suggest similar trafficking routes through 
the recycling compartments. 
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1. Introduction 
Insulin stimulates glucose transport in rat adipose cells by 
inducing the translocation of the GLUT4 glucose transporter 
from an intracellular compartment to the plasma membrane. 
This mechanism is supported by both biochemical and immu-
nocytochemical analyses [1^1]. However, many questions re-
garding the localization and trafficking pathways of GLUT4 
remain unanswered. It is unclear, for example, whether in the 
absence of insulin, GLUT4 storage vesicles represent a sepa-
rate, distinct class of vesicles. Support in favor of an unique 
intracellular GLUT4 compartment in insulin-responsive cells 
comes from very recent data using in situ biochemical abla-
tion of the endosomal system in 3T3-L1 adipocytes [5] and 
confocal microscopy in whole rat adipose cells [6]. These stud-
ies suggest that in the absence of insulin, GLUT4 is segregated 
from the compartment containing the recycling receptors. 
Furthermore, previous in vitro studies of the protein compo-
sition of GLUT4-containing vesicles reveals the presence of 
*Corresponding author. EDMNS/DB/NIDDK/NIH, Bldg. 10, 
Room 5N102, 10 Center Drive MSC 1420, Bethesda, MD 20892-1420, 
USA. Fax: (301) 402-0432. 
E-mail : danielam@bdgl0.niddk.nih.gov 
Abbreviations: VAMP2, vesicle-associated membrane protein 2; 
SCAMP, secretory carrier membrane protein(s); vpl65, vesicle protein 
165; PM, plasma membrane(s); LDM, low-density microsome(s) ; 
HDM, high-density microsome(s) ; FITC, fluorescein isothiocyanate ; 
LRSC, lissamine rhodamine sulfonyl chloride ; PAGE, polyacrylamide 
gel electrophoresis 
synaptobrevins, vesicle associated membrane protein 2 
(VAMP2) [5,7-9] and cellubrevin (VAMP3) [5,9,10]; secretory 
carrier membrane proteins (SCAMP) [11]; phosphatidylinosi-
tol 4-kinase [12]; and the GTP-binding protein Rab4 [13,14]. 
In addition, a protein designated vpl65 for vesicle protein of 
MW 165 kDa or gpl60 for glycoprotein of MW 160 kDa has 
been purified from GLUT4-containing vesicles by two labo-
ratories and has been identified as a zinc-dependent amino-
peptidase [15-18]. By immunoblotting of subcellular frac-
tions it was shown that vpl65 redistributes to the cell 
surface upon insulin stimulation in rat adipose cells [15,17], 
3T3-L1 adipocytes [19], and L6 muscle cells [20] to a similar 
extent as GLUT4 and that vpl65 colocalizes with GLUT4 to 
the same vesicles obtained in vitro by cell homogenization 
[19,20]. 
However, the questions of whether vpl65 and GLUT4 are 
entirely co-localized in vesicles within intact cells and trans-
locate in a quantitatively similar way in response to insulin 
have not been addressed in rat adipose cells. Moreover, a 
morphological analysis of trafficking events during the re-in-
ternalization of vpl65 and GLUT4 has not been described. 
Thus, we decided to take advantage of the effects of the fungal 
metabolite wortmannin (WT). Several biochemical kinetic 
studies in rat adipose cells and 3T3-L1 adipocytes have pre-
viously demonstrated that wortmannin inhibits the stimula-
tory effect of insulin on glucose transport by blocking the 
translocation of GLUT4 to the plasma membrane [21-24]. 
More recently, we have performed a morphological study in 
rat adipose cells of the effects of wortmannin on the subcel-
lular distributions of GLUT4 and several membrane proteins 
used as 'compartment markers' [25]. Briefly, our data demon-
strate that WT affects both the exocytic and endocytic limbs 
of the GLUT4 trafficking pathway. When added before insu-
lin, WT blocks the insulin-stimulated GLUT4 translocation 
and conserves the basal GLUT4 compartment. When added 
after insulin, WT induces a redistribution of GLUT4 into 
endosomal-derived large phase-lucent vacuoles. 
In the present report, we performed combined studies, using 
both double immunofluorescence confocal microscopy and 
biochemical approaches, to analyze GLUT4 and vpl65 distri-
butions in an insulin target cell of physiological significance. 
We further investigated by WT treatment the morphological 
details of exocytosis and endocytosis along the translocation 
and recycling pathways of vpl65 and GLUT4. Our data have 
led us to conclude that in rat adipose cells vpl65 and GLUT4 
share the same vesicle populations moving both towards and 
from the plasma membrane. These data are consistent with 
the existence of a distinct insulin-sensitive compartment that 
sequesters both GLUT4 and vpl65. Interestingly, these results 
also provide evidence that vpl65 and GLUT4 follow similar 
traffic routes through the recycling compartments. 
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2. Materials and methods 
2.1. Preparation and incubation of the adipose cells 
Adipose cells were isolated by collagenase digestion from the epi-
didymal fat pads of 180-250 g male Sprague-Dawley rats as previ-
ously described [1,26]. Isolated white adipose cells (2^1 X 106 cells/ml) 
were incubated without or with 700 nM insulin (Eli Lilly, Indiana-
polis, IN) at 37°C for 45 min. In experiments investigating the effects 
of WT (Sigma, St. Louis, MO), the drug was dissolved in dimethyl 
sulfoxide (DMSO) and added to the cells at a final concentration of 
100 nM. 
2.2. Glucose transport 
Glucose transport activity was assessed by the tracer [U-14C]glucose 
uptake method [27]. 
2.3. Preparation of subcellular membrane fractions 
Homogenization and subcellular fractionation of adipose cells were 
carried out according to the method of Simpson et al. [1]. Briefly, cells 
were washed twice with TES buffer (25 mM Tris-HCl, 250 mM su-
crose, 2 mM EDTA, pH 7.4) containing 0.12 mM 4-(2-aminoethyl)-
benzenesulphonyl fluoride, 10 ug/ml aprotinin, and 10 u.g/ml leupeptin 
at 18°C, and homogenized with a Potter-Elvehjem teflon pestle. Sub-
cellular membrane fractions, plasma membranes (PM), high-density 
microsomes (HDM), and low-density microsomes (LDM), were ob-
tained by differential centrifugation. 
2.4. Antibodies 
For GLUT4, we employed a rabbit polyclonal antiserum kindly 
provided by Hoffmann-La Roche (Nutley, NJ) and a mouse mono-
clonal antibody, F-27, kindly provided by Dr. P.N. Jorgensen of 
Novo Nordisk (Bagsvaerd, Denmark). Both antibodies are directed 
to C-terminal sequences of GLUT4 (of 20 and 14 amino acid residues, 
respectively) and their specificities were previously demonstrated by 
immunochemical and immunocytochemical techniques [6,28-30]. For 
vpl65 we employed an affinity-purified rabbit polyclonal IgG raised 
against the cytoplasmic domain of vpl65, previously used in both 
immunochemical and immunofluorescence studies on 3T3-L1 adipo-
cytes [16,19]. Fluorescein isothiocyanate (FITC)- and lissamine rhod-
amine sulfonyl chloride (LRSC)-conjugated antibodies specific for 
rabbit or mouse immunoglobulins (Ig), used as secondary antibodies 
in immunofluorescence experiments, were obtained from Jackson Im-
munoResearch (West Grove, PA). 
2.5. Gel electrophoresis and Immunoblotting 
Membrane proteins were separated by SDS-PAGE (Bio-Rad Lab-
oratories, Hercules, CA). 12% and 8% polyacrylamide gels were used 
to resolve GLUT4 and vpl65, respectively. Proteins were then trans-
ferred to nitrocellulose membranes (Schleicher and Schuell, Keene, 
NH) in 25 mM Tris-HCl, 192 mM glycine, 20% methanol buffer, 
pH 8.6, at 300 mA for 16 h. Membranes were blocked with 5% 
non-fat dry milk in 10 mM Tris-HCl, 0.9% NaCl buffer, pH 7.4. 
GLUT4 and vpl65 were detected with specific antibodies, a rabbit 
polyclonal anti-GLUT4 (1:4000 dilution from whole serum) and an 
affinity-purified rabbit polyclonal anti-vpl65 (3 ug/ml), respectively, 
followed by 125I-labeled protein A as previously described [9]. Immu-
noreactive band intensities were quantified using a Molecular Dynam-
ics computing densitometer (Molecular Dynamics, Sunnyvale, CA). 
2.6. Immunocytochemistry 
Single and double immunofluorescence experiments were performed 
using 4% paraformaldehyde-fixed adipose cells in suspension follow-
ing the protocol described in detail elsewhere [6]. The cells were in-
cubated sequentially in two steps with pairs of the specific primary 
followed by the corresponding secondary antibodies. Thus, the mono-
clonal anti-GLUT4 antibodies (1 ug/mi) in conjunction with the rhod-
amine-conjugated goat anti-mouse antibodies were followed by the 
polyclonal anti-vpl65 antibodies (5 ug/ml) in conjunction with the 
FITC-conjugated goat anti-rabbit antibodies. The immunostained 
cells were viewed by the Nikon Optiphot 2 fluorescence microscope 
equipped with a Bio-Rad MRC1024 confocal laser scanning imaging 
system (CLSM) from Bio-Rad Labs (Hercules, CA). This system uti-
lizes a mixed argon/krypton laser (K\ =488 nm, blue line for FITC; 
%i = 568 nm, yellow line for rhodamine) and Lasersharp image anal-
ysis software. Specimens were viewed using a planapochromat X60/ 
Fig. 1. Glucose transport activity in rat adipose cells. [U-
14C]Glucose uptake was measured as described in Section 2 in cells 
that were either (1) untreated (DMSO 0.1% alone), (2) treated with 
WT for 45 min, (3) stimulated with insulin for 45 min, (4) stimu-
lated with insulin for 15 min followed by addition of WT for the 
next 30 min in the continuous presence of insulin, or (5) treated si-
multaneously with insulin and WT for 45 min. Results are the 
means ± SD of triplicate determinations obtained in a representative 
experiment (n = 5). 
1,4NA oil immersion objective. For each experimental condition, 8-10 
images/cell were recorded from at least 1CM5 cells. Series of optical 
sections were collected sequentially at 0.5-um intervals along the Z-
axis for the two fluorochromes in the double-labeling experiments 
using Kaiman averaging at an optical zoom setting of 1-2.5 [31]. 
Co-localization was assessed throughout the cell by examination of 
merged images and was expressed as 'high' when the overlap was 
present in all focal planes, 'partial' when the overlap was present in 
1-3 focal planes, and 'absent' when no significant overlap was ob-
served. For presentation, images were further enhanced digitally using 
the Adobe Photoshop 3.0 program from Adobe Systems (Mountain 
View, CA) and printed with a Kodak 8650 PS digital printer (East-
man Kodak, New Haven, CT). 
3. Results and discussion 
Recent biochemical studies clearly show that the subcellular 
distributions of vp l65 and G L U T 4 are concordant, and thus 
we were prompted to analyze this co-localization in situ in 
adipose cells under experimental conditions which allow dis-
section of both the exocytic and endocytic steps of their traf-
ficking pathways. Although the biochemical analysis of immu-
noisolated GLUT4-containing vesicles has contributed much 
to characterizing the protein composition of the G L U T 4 com-
partments, the precise localization of these various proteins in 
intact cells under steady-state conditions is needed as a basis 
to clarify further their functional roles. 
Fig. 1 illustrates the glucose transport activity of isolated 
rat adipose cells under several experimental conditions. W T 
slightly decreases basal glucose transport activity consistent 
with previous data in 3T3-L1 adipocytes [24], while insulin 
stimulates a 7-fold increase in glucose t ransport activity com-
pared to basal values. In the presence of insulin, W T com-
pletely reverses the stimulation of glucose transport activity 
when added 15 min after insulin and completely prevents the 
stimulation of glucose transport activity when added concom-
itantly with insulin. 
The subcellular distributions of vp l65 and G L U T 4 between 
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Fig. 2. Subcellular distributions of vpl65 and GLUT4 in rat adipose cells. Plasma membrane (PM) and low-density microsome (LDM) frac-
tions were prepared from samples of cells from the experiment shown in Fig. 1, as described in Section 2. Membrane proteins (20 ug/lane) 
were resolved by SDS-PAGE (8% for vpl65 and 12% for GLUT4), transferred to nitrocellulose paper, and probed with vpl65 and GLUT4 
polyclonal antibodies in conjunction with 125I-labeled protein A. Western blot data were quantified as phosphorimager relative units per 20 |ig 
of membrane protein in PM and LDM. Because of the consistency of the current results for the basal and insulin-stimulated states with pub-
lished data, only this one Western blotting experiment was carried out. 
PM and LDM prepared from adipose cells treated as just 
described are shown in Fig. 2. In PM from WT-treated cells, 
vpl65 and GLUT4 both appear to be slightly decreased com-
pared to PM from basal cells. In the corresponding LDM of 
WT-treated cells, vp!65 and GLUT4 do not change signifi-
cantly compared to the basal patterns. In PM from insulin-
stimulated cells, vpl65 and GLUT4 show parallel increases 
compared to PM from basal cells (5.3-fold and 7.6-fold, re-
spectively). This redistribution to the plasma membrane is 
accompanied by parallel decreases of vpl65 and GLUT4 in 
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Fig. 3. Co-localization of vpl65 and GLUT4 in basal rat adipose cells. Images from the same confocal optical sections double labeled for 
vpl65 (A,C,E) and GLUT4 (B,D,F) are presented side by side. For most confocal sections through the middle (A,B) and closer to the surface 
(C,D) of rat adipose cells, very similar intracellular punctate staining is observed for vpl65 and GLUT4. In contrast, in the perinuclear region, 
vpl65 exhibit only weak punctate immunonuorescence partially co-stained by GLUT4; the latter is present also in 'large dots' distinct from 
vpl65 (E-F). Bars: 10 um. 
LDM (58% and 76%, respectively). The distributions of first with insulin for 15 min followed by the addition of WT 
GLUT4 and vp!65 in subcellular fractions of cells incubated or incubated simultaneously with WT and insulin are un-
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Fig. 4. Comparable translocation of vpl65 and GLUT4 to the cell surface in insulin-treated rat adipose cells. Images from the same confocal 
optical sections double labeled for vpl65 (A,C) and GLUT4 (B,D) are presented side by side. In confocal cross-sections (A,B), the cell surface 
staining of vpl65 and GLUT4 can be seen outlining the periphery of the cell; in grazing views (C,D), the vpl65 and GLUT4 staining can be 
seen obscuring the visualization of the lipid droplet. Note the high degree of correspondence of vpl65 and GLUT4 immunofluorescence. Bars: 
10 um. 
changed compared to their respective basal distributions. 
Thus WT reverses the effects of insulin when added after in-
sulin and blocks the effects of insulin when added to cells 
together with insulin. These results are consistent with the 
insulin-stimulated increases of vpl65 and GLUT4 in PM of 
rat adipose cells reported previously [15,17]. In addition, we 
demonstrate here comparable inhibitory effects of WT on the 
insulin-stimulated translocation of vpl65 and GLUT4 in rat 
adipose cells. Finally, our data using WT treatment following 
insulin stimulation reveal a remarkable parallelism between 
the subcellular distributions of vpl65 and GLUT4 along the 
return pathway from the plasma membrane to the intracellu-
lar compartment as well. 
Because the observed parallelism of vpl65 and GLUT4 in 
subcellular membrane fractions does not necessarily prove 
their co-localization in the same vesicle, we next used confocal 
microscopy to directly visualize their subcellular distributions. 
Adipose cells were incubated under the experimental condi-
tions described above and then double labeled for vpl65 and 
GLUT4. When cells are incubated in the absence of insulin 
(basal cells), we observe very similar patterns and almost com-
plete overlap of immunofluorescence for vpl65 and GLUT4 
(Fig. 3). Confocal optical sections (0.2 u,m in thickness) 
through the middle, closer to the surface, and through the 
perinuclear area of a rat adipose cell are presented. The stain-
ing is almost entirely intracellular and found in the perinu-
clear region and in fine punctate spots distributed throughout 
the cytoplasm (Fig. 3A,B). Only weak staining is observed at 
the cell surface (Fig. 3C,D). A high degree of co-localization is 
demonstrated in most confocal cross-sections (Fig. 3A,B) and 
grazing sections (Fig. 3C,D). In contrast, in the perinuclear 
region overlap is not complete; close examination reveals 
some differences in the distributions and immunofluorescence 
patterns of the proteins. In this region GLUT4 exhibit a fine 
punctate staining with partial overlap with vpl65 and a 'large 
dot' staining for the most part distinct from vpl65 (Fig. 
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Fig. 5. Co-localization of vpl65 and GLUT4 in WT-treated rat adipose cells. Images from the same confocal optical sections double labeled 
for vpl65 (A,C) and GLUT4 (B,D) are presented side by side. In grazing sections of WT-treated cells (A,B), vpl65 and GLUT4 exhibit a re-
markably similar intracellular punctate pattern indistinguishable from that seen with basal cells (Fig. 3). In grazing sections of cells incubated 
with insulin followed by the addition of WT in the continuous presence of insulin (C,D), vpl65 and GLUT4 immunofluorescence coincides for 
the most part in vacuoles and vesicle-like structures. WT-induced phase-lucent vacuoles are illustrated in a phase micrograph (E) and a corre-
sponding GLUT4 immunofluorescence image (F). Bars: 10 urn (A,B,C,D); 5 um (E,F). 
D. Malide et al.lFEBS Letters 409 (1997) 461-468 467 
3E,F). A semi-quantitative estimation of the degree of the 
overlap suggests that approximately 85% of the total 
GLUT4-containing vesicles present in a cell contains vpl65 
as well. 
Several control experiments were performed to confirm the 
specificity of these results (not shown). Staining of the adipose 
cells with normal non-immune rabbit or mouse sera instead of 
the primary antibodies was not detectable. 
After a 45-min treatment with insulin, very similar redis-
tributions of vpl65 and GLUT4 immunofluorescence to the 
cell surface are observed (Fig. 4A-D). Highly comparable co-
staining is shown in most of the cross-sections (Fig. 4A,B) and 
grazing sections (Fig. 4C,D) examined. 
The effects of WT observed in the present study on the 
subcellular distributions of vpl65 and GLUT4 are summar-
ized in Fig. 5. Wortmannin does not significantly affect the 
basal patterns of vpl65 and GLUT4 staining (Fig. 5A,B), but 
prevents the insulin-stimulated appearance of immunodetect-
able vpl65 and GLUT4 on the cell surface (data not shown). 
Under both these conditions, vpl65 and GLUT4 immuno-
fluorescence exhibits an intracellular punctate pattern indistin-
guishable from the basal staining (Fig. 5A,B). It is well docu-
mented in other cell types that WT induces morphological 
perturbations in the endosomal system in the absence of in-
sulin [32-36]. Furthermore, in a CHO cell line overexpressing 
transferrin receptors, Martys et al. [34] have shown that WT 
treatment induces a redistribution of transferrin receptors to 
the morphologically altered compartment along with a slowed 
rate of receptor recycling. In contrast, our data show that the 
recycling of GLUT4 and vpl65 under basal conditions is not 
changed by WT. Assuming that the recycling of transferrin 
receptors under basal conditions in rat adipose cells is the 
same as that in CHO cells, it is clearly different from those 
of vpl65 and GLUT4. Of particular interest is our observa-
tion that although morphological alterations are present rat 
adipose cells in the form of large phase-lucent vacuoles (Fig. 
5E), these vacuoles are devoid of GLUT4 and vpl65. These 
data suggest that in the absence of insulin both proteins are 
outside the endosomal system, thus further supporting the 
concept of a specialized basal GLUT4 compartment. 
By incubating cells with insulin for 15 min to induce trans-
location to the plasma membrane and then adding WT for the 
next 30 min to block further translocation despite the contin-
uous presence of insulin, we were able to follow by immuno-
fluorescence the internalization and return of vpl65 and 
GLUT4 to the intracellular compartments (Fig. 5C-F). Con-
sistent with our previous observations, WT induces the for-
mation of phase-lucent vacuoles (Fig. 5E) which stain for 
GLUT4 (Fig. 5F). Likewise, vpl65 show almost complete 
co-localization with GLUT4 in these vacuoles and throughout 
the remaining vesicle-like structures (Fig. 5C,D). However, 
the effects of WT on the distributions of vpl65 and GLUT4 
observed in insulin-treated adipose cells may not be specific 
only for these proteins. These changes probably reflect the 
trafficking of vpl65 and GLUT4 through multiple WT-sensi-
tive steps along the endocytic pathway. Several recent reports 
have documented that WT directly affects both receptor-medi-
ated and fluid-phase endocytosis [32-36]. Our data are in 
agreement with these studies and add more support to the 
concept that both vpl65 and GLUT4 are internalized and 
recycled through the endocytic pathway together with other 
membrane proteins. 
In conclusion, at the level of resolution of confocal micro-
scopy, the pattern of vpl65 distribution closely resembles that 
of GLUT4 in the basal intracellular compartment indicating 
that both proteins reside in the same vesicle. Further, our data 
strongly indicate that vpl65 and GLUT4 travel as part of an 
identical vesicle pool translocated to the plasma membrane in 
response to insulin. Interestingly, the use of WT provides 
direct evidence for the localization of both proteins in similar 
endocytic vesicles after re-internalization from the plasma 
membrane. These results are consistent with vpl65 and 
GLUT4 residing in and recycling through the same subcellu-
lar compartments. Because the role of the aminopeptidase 
vpl65 remains largely unknown, the significance of the pres-
ence of vpl65 within GLUT4-containing vesicles is as yet 
unclear. Moreover, the expression of vpl65 is not restricted 
to cells expressing GLUT4 [16]. Whether vpl65 plays a role in 
the biogenesis of GLUT4 vesicles or in their fusion with the 
plasma membrane remains to be established. 
Acknowledgements: We thank Mary Jane Zarnowski and Steven R. 
Richards for their expert technical assistance. We are grateful to Dr. 
Gustav E. Lienhard, Dr. Ian A. Simpson, and Dr. Marc Reitman for 
their continuous help and encouragement, and critical reading of the 
manuscript. 
References 
[1] Simpson, I.A., Yver, D.R., Hissin, P.J., Wardzala, L.J., Karnieli, 
E., Salans, L.B., Cushman, S.W., Biochem. Biophys. Acta 763 
(1983) 393^107. 
[2] Satoh, S., Nishimura, H., Clark, A.E., Kozka, I.J., Vannucci, 
S.J., Simpson, I.A., Quon, M.J., Cushman, S.W., Holman, 
G.D., J. Biol. Chem. 268 (1993) 17820-17829. 
[3] Slot, J.W., Geuze, HJ., Gigengack, S., Lienhard, G.E., James, 
D.E., J. Cell Biol. 113 (1991) 123-135. 
[4] Smith, R.M., Charron, M.J., Shah, N., Lodish, H.F., Jarett, L., 
Proc. Natl. Acad. Sei. USA 88 (1991) 6893-6897. 
[5] Martin, S., Tellam, J., Livingstone, C, Slot, J.W., Gould, G.W., 
James, D.E., J. Cell Biol. 134 (1996) 625-635. 
[6] Malide, D., Dwyer, N.K., Blanchette-Mackie, E.J. and Cushman, 
S.W. (1997) J. Histochem. Cytochem., in press. 
[7] Cain, C.C., Trimble, W.S., Lienhard, G.E., J. Biol. Chem. 267 
(1992) 11681-11684. 
[8] Volchuk, A., Mitsumoto, Y., He, L., Lui, Z., Habermann, E., 
Trimble, W.S., Klip, A., Biochem. J. 304 (1994) 139-145. 
[9] Timmers, K.I., Clark, A.E., Omatsu-Kanbe, M., Whiteheart, 
S.W., Bennett, M.K., Holman, G.D., Cushman, S.W., Biochem. 
J. 320 (1996) 429-436. 
[10] Volchuk, A., Sargeant, R., Sumitani, S., Lui, Z., He, L., Klip, A., 
J. Biol. Chem. 270 (1995) 8233-8240. 
[11] Laurie, S.M., Cain, C.C., Lienhard, G.E., Castle, J.D., J. Biol. 
Chem. 268 (1993) 19110-19117. 
[12] Del Vecchio, R.L., Pilch, P.F., J. Biol. Chem. 266 (1991) 13278-
13283. 
[13] Cormont, M., Tanti, J.-F., Gremeaux, T., Van Obberghen, E., Le 
Marchand-Brustel, Y., Endocrinology 129 (1991) 3343-3350. 
[14] Cormont, M., Tanti, J.-F., Zahraoui, A., Van Obberghen, E., 
Tavitian, A., Le Marchand-Brustel, Y., J. Biol. Chem. 268 
(1993) 19491-19497. 
[15] Mastick, C.C., Aebersold, R., Lienhard, G.E., J. Biol. Chem. 269 
(1994) 6089-6092. 
[16] Keller, S.R., Scott, H.M., Mastick, C.C., Aebersold, R., Lien-
hard, G.E., J. Biol. Chem. 270 (1995) 23612-23618. 
[17] Kandror, K.V., Pilch, P.F., Proc. Natl. Acad. Sei. USA 91 (1994) 
8017-8021. 
[18] Kandror, K.V., Yu, L., Pilch, P.F., J. Biol. Chem. 269 (1994) 
30777-30780. 
[19] Ross, S.A., Scott, H.M., Morris, N.J., Leung, W.Y., Mao, F., 
Lienhard, G.E., Keller, S.R., J. Biol. Chem. 271 (1996) 3328-
3332. 
468 D. Malide et al.lFEBS Letters 409 (1997) 461^68 
[20] Sumitani, S., Ramlal, T., Somwar, R., Keller, S.R., Klip, A., 
Endocrinology 138 (1997) 1029-1034. 
[21] Clarke, J.F., Young, P.W., Yonezawa, K., Kasuga, M., Holman, 
G.D., Biochem. J. 300 (1994) 631-635. 
[22] Okada, T., Kawano, Y., Sakakibara, T., Hazeki, O., Ui, M., 
J. Biol. Chem. 269 (1994) 3568-3573. 
[23] Cheatham, B., Vlahos, C.J., Cheatham, L., Wang, L., Blenis, J., 
Kahn, C.R., Mol. Cell. Biol. 14 (1994) 4902-4911. 
[24] Yang, J., Clarke, J.F., Ester, C.J., Young, P.W., Kasuga, M., 
Holman, G.D., Biochem. J. 313 (1996) 125-131. 
[25] Malide, D., Dwyer, N.K., Blanchette-Mackie, E J . and Cushman, 
S.W. (1996) Diabetes 45, Suppl. 2, p88A (abstract). 
[26] Weber, T.M., Joost, H.G., Simpson, I.A. and Cushman, S.W. 
(1988) in: The insulin receptor (Kahn, C.R. and Harrison, 
L.C., eds.), Part B, pp. 171-187, Alan R. Liss, New York. 
[27] Foley, J.E., Kashiwagi, A., Verso, M.A., Reaven, G., Andrews, 
J., J. Clin. Invest. 72 (1983) 1901-1909. 
[28] Holman, G.D., Kozka, I.J., Clark, A.E., Flower, C.J., Saltis, J., 
Habberfield, A.D., Simpson, I.A., Cushman, S.W., J. Biol. 
Chem. 265 (1990) 18172-18179. 
[29] Ploug, T., Wojtaszewski, J., Kristiansen, S., Hespel, P., Galbo, 
H., Richter, E.A., Am. J. Physiol. 264 (1993) E270-E278. 
[30] Voldstedlund, M., Tranum-Jensen, J., Vinten, J., J. Membrane 
Biol. 136 (1993) 63-73. 
[31] Wright, S.J., Centonze, V.E., Stricker, S.A., De Vries, P.J., Pad-
dock, S.W. and Schatten, (1993) in: Cell biological applications 
of confocal microscopy (Matsumoto, B. ed.), Methods Cell Biol. 
Vol. 38, pp. 1-45, Academic Press, San Diego, CA. 
[32] Brown, W.J., DeWald, D.B., Emr, S.D., Plutner, H., Balch, 
W.B., J. Cell Biol. 130 (1995) 781-796. 
[33] Joly, M., Kazlauskas, A., Corvera, S., J. Biol. Chem. 270 (1995) 
13225-13230. 
[34] Martys, J.L., Wjasow, C , Gangi, D.M., Kielian, M.C., McGraw, 
T.E., Backer, J.M., J. Biol. Chem. 271 (1996) 10953-10962. 
[35] Spiro, D.J., Boll, W., Kirchhausen, T., Wessling-Resnick, M., 
Mol. Biol. Cell. 7 (1996) 355-367. 
[36] Reaves, B.J., Bright, N.A., Mullock, B.M., Luzio, J.P., J. Cell 
Sei. 109 (1996) 749-762. 
